Glucagon-like peptide-1 receptor agonist and basal insulin combination treatment for the management of type 2 diabetes: a systematic review and meta-analysis

Conrad Eng; Caroline K Kramer; Bernard Zinman; Ravi Retnakaran

doi:10.1016/s0140-6736(14)61335-0

Glucagon-like peptide-1 receptor agonist and basal insulin combination treatment for the management of type 2 diabetes: a systematic review and meta-analysis

The Lancet ◽

10.1016/s0140-6736(14)61335-0 ◽

2014 ◽

Vol 384 (9961) ◽

pp. 2228-2234 ◽

Cited By ~ 244

Author(s):

Conrad Eng ◽

Caroline K Kramer ◽

Bernard Zinman ◽

Ravi Retnakaran

Keyword(s):

Systematic Review ◽

Type 2 Diabetes ◽

Combination Treatment ◽

Basal Insulin ◽

Receptor Agonist ◽

Meta Analysis ◽

Glucagon Like Peptide ◽

Glucagon Like Peptide 1

Download Full-text

The good companions: insulin and glucagon-like peptide-1 receptor agonist in type 2 diabetes. A systematic review and meta-analysis of randomized controlled trials

Diabetes Research and Clinical Practice ◽

10.1016/j.diabres.2019.06.009 ◽

2019 ◽

Vol 154 ◽

pp. 101-115 ◽

Cited By ~ 5

Author(s):

Maria Ida Maiorino ◽

Paolo Chiodini ◽

Giuseppe Bellastella ◽

Lorenzo Scappaticcio ◽

Miriam Longo ◽

...

Keyword(s):

Systematic Review ◽

Type 2 Diabetes ◽

Randomized Controlled Trials ◽

Receptor Agonist ◽

Meta Analysis ◽

Controlled Trials ◽

Randomized Controlled ◽

Glucagon Like Peptide ◽

Glucagon Like Peptide 1

Download Full-text

Insulin and Glucagon-Like Peptide 1 Receptor Agonist Combination Therapy in Type 2 Diabetes: A Systematic Review and Meta-analysis of Randomized Controlled Trials

Diabetes Care ◽

10.2337/dc16-1957 ◽

2017 ◽

Vol 40 (4) ◽

pp. 614-624 ◽

Cited By ~ 52

Author(s):

Maria Ida Maiorino ◽

Paolo Chiodini ◽

Giuseppe Bellastella ◽

Annalisa Capuano ◽

Katherine Esposito ◽

...

Keyword(s):

Systematic Review ◽

Type 2 Diabetes ◽

Combination Therapy ◽

Receptor Agonist ◽

Meta Analysis ◽

Controlled Trials ◽

Randomized Controlled ◽

Glucagon Like Peptide ◽

Glucagon Like Peptide 1

Download Full-text

Glucagon-like peptide 1 receptor agonist therapy is more efficacious than insulin glargine for poorly controlled type 2 diabetes: A systematic review and meta-analysis

Journal of Diabetes ◽

10.1111/1753-0407.12200 ◽

2014 ◽

Vol 7 (3) ◽

pp. 322-328 ◽

Cited By ~ 14

Author(s):

Fu-peng Liu ◽

Jian-jun Dong ◽

Qing Yang ◽

Xian-zhong Xue ◽

Zhong-fa Ren ◽

...

Keyword(s):

Systematic Review ◽

Type 2 Diabetes ◽

Insulin Glargine ◽

Receptor Agonist ◽

Meta Analysis ◽

Agonist Therapy ◽

Glucagon Like Peptide ◽

Glucagon Like Peptide 1

Download Full-text

Efficacy and Safety of Glucagon-Like Peptide-1 Receptor Agonist (GLP-1RA) plus Basal Insulin vs. GLP-1RA in Type 2 Diabetes Mellitus—A Systematic Review and Meta-analysis

Diabetes ◽

10.2337/db18-1108-p ◽

2018 ◽

Vol 67 (Supplement 1) ◽

pp. 1108-P

Author(s):

MUNIZA M. SATTI ◽

TIMOTHY O'BRIEN ◽

AARON LIEW

Keyword(s):

Diabetes Mellitus ◽

Systematic Review ◽

Type 2 Diabetes ◽

Type 2 Diabetes Mellitus ◽

Receptor Agonist ◽

Meta Analysis ◽

Efficacy And Safety ◽

Glucagon Like Peptide ◽

Glucagon Like Peptide 1

Download Full-text

Safety and efficacy of a glucagon-like peptide-1 receptor agonist added to basal insulin therapy versus basal insulin with or without a rapid-acting insulin in patients with type 2 diabetes: results of a meta-analysis

Postgraduate Medicine ◽

10.1080/00325481.2017.1297669 ◽

2017 ◽

Vol 129 (4) ◽

pp. 436-445 ◽

Cited By ~ 15

Author(s):

Carol H. Wysham ◽

Jay Lin ◽

Louis Kuritzky

Keyword(s):

Type 2 Diabetes ◽

Insulin Therapy ◽

Basal Insulin ◽

Receptor Agonist ◽

Meta Analysis ◽

Safety And Efficacy ◽

Acting Insulin ◽

Glucagon Like Peptide ◽

Glucagon Like Peptide 1

Download Full-text

Faculty Opinions recommendation of Association Between Use of Sodium-Glucose Cotransporter 2 Inhibitors, Glucagon-like Peptide 1 Agonists, and Dipeptidyl Peptidase 4 Inhibitors With All-Cause Mortality in Patients With Type 2 Diabetes: A Systematic Review and Meta-analysis.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.733073791.793548836 ◽

2018 ◽

Author(s):

Helmy Siragy

Keyword(s):

Systematic Review ◽

Type 2 Diabetes ◽

Meta Analysis ◽

Dipeptidyl Peptidase 4 ◽

Sodium Glucose Cotransporter ◽

Dipeptidyl Peptidase 4 Inhibitors ◽

All Cause Mortality ◽

Glucagon Like Peptide ◽

Glucagon Like Peptide 1

Download Full-text

Glucagon-Like Peptide 1 Receptor Agonist (GLP1RA) Exposure and Outcomes in Type 2 Diabetes: A Systematic Review of Population-Based Observational Studies

Diabetes Therapy ◽

10.1007/s13300-021-01021-1 ◽

2021 ◽

Author(s):

Thomas M. Caparrotta ◽

Jack B. Templeton ◽

Thomas A. Clay ◽

Sarah H. Wild ◽

Rebecca M. Reynolds ◽

...

Keyword(s):

Systematic Review ◽

Type 2 Diabetes ◽

Observational Studies ◽

Receptor Agonist ◽

Population Based ◽

Glucagon Like Peptide ◽

Glucagon Like Peptide 1

Download Full-text

Efficacy and safety of long-acting glucagon-like peptide-1 receptor agonist dulaglutide in patients with type 2 diabetes: a systematic review and meta-analysis of 21 randomized controlled trials

Endocrine ◽

10.1007/s12020-020-02193-9 ◽

2020 ◽

Vol 68 (3) ◽

pp. 508-517 ◽

Cited By ~ 2

Author(s):

Suhui Qie ◽

Xuejing Li ◽

Xianying Wang ◽

Yang Liu ◽

Jingxin Li ◽

...

Keyword(s):

Systematic Review ◽

Receptor Agonist ◽

Meta Analysis ◽

Controlled Trials ◽

Efficacy And Safety ◽

Randomized Controlled ◽

Glucagon Like Peptide ◽

Glucagon Like Peptide 1 ◽

Long Acting

Download Full-text

Review for "Glucagon‐like peptide 1 receptor agonists and sodium glucose co‐transporter 2 inhibitors as combination therapy for type 2 diabetes. A systematic review and meta‐analysis"

10.1111/dom.14108/v2/review1 ◽

2020 ◽

Author(s):

Ling Li

Keyword(s):

Systematic Review ◽

Type 2 Diabetes ◽

Combination Therapy ◽

Meta Analysis ◽

Receptor Agonists ◽

Glucagon Like Peptide ◽

Glucagon Like Peptide 1

Download Full-text

Review for "Glucagon‐like peptide 1 receptor agonists and sodium glucose co‐transporter 2 inhibitors as combination therapy for type 2 diabetes. A systematic review and meta‐analysis"

10.1111/dom.14108/v1/review6 ◽

2020 ◽

Author(s):

Raquel Comoglio

Keyword(s):

Systematic Review ◽

Type 2 Diabetes ◽

Combination Therapy ◽

Meta Analysis ◽

Receptor Agonists ◽

Glucagon Like Peptide ◽

Glucagon Like Peptide 1

Download Full-text